• Main slide - structure search -green

  • deal-of-the-week-pic-with-click-here

Quanta BioDesign

Quanta BioDesign is a research and manufacturing company committed to the development of a full range of discrete polyethylene glycol (dPEG®) PEGylation reagents for applications in diagnostics, therapeutics, peptide synthesis, oligonucleotide synthesis, and nanotechnology.

Quanta BioDesign’s vision incorporates a dedicated commitment to producing the most useful compounds for your current and future applications and needs using synthetic and process technology that allows the most economic incorporation of these products into your application.



Bioconjugates – From Targets to Therapeutics

Dr. Paul D. Davis, Ph.D. will be speaking June 5, 8:15 am
June 5-7, 2017
Paradise Point Resort
San Diego, CA


Booth # 12
September 20-22, 2017
Sheraton San Diego Marina
San Diego, CA